CRTAP is found in articular chondrocytes and is expressed in a variety of other tissues. Defects in CRTAP are the cause of osteogenesis imperfecta type 7 (OI-7). OI is a connective tissue disorder characterized by bone fragility and low bone mass. OI-7 is an autosomal recessive form of OI.
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More
Citations
Have you cited DPABH-24429 in a publication? Let us know and earn a reward for your research.
Grafel, I; Yang, T; et al. Excessive transforming growth factor-beta signaling is a common mechanism in osteogenesis imperfecta. NATURE MEDICINE 20:670-675(2014).
Grafe, I; Yang, T; et al. Sclerostin antibody treatment improves bone mass and microarchitectural parameters in young Crtap-/- mice, a model of pediatric recessive Osteogenesis Imperfecta. JOURNAL OF BONE AND MINERAL RESEARCH 28:-(2013).
Payment methods we support:
Invoice / Purchase Order
Credit card
My Review for Anti-CRTAP polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Certificate of Analysis